Novavax

Novavax

Late-stage biotechnology company focused on the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. Learn more

Launch date
Employees
Market cap
€1.7b
Enterprise valuation
€991m (Public information from Sep 2024)
Gaithersburg Maryland (HQ)
Authorizing premium user...